Friday, May 16, 2014 1:23:48 PM
Yes, interesting. Actual dollars are not large, but someone actually wants a few of the shares. Maybe the company has found a pump/dump shop, which means shareholders may be about to be taken for a wild ride.
P/D shops love brain damaged OTC penny stocks with shelf registrations. They orchestrate a rally (look at PLUG) and generate much trading activity, while steadily establishing a short position. They cover the short with below market S-1 at nice profit and get free warrants as added sweetener. Seen this happen with several companies recently.
This process does produce cash for the company, abet at cost of dilution. It's a lot better for Platinum than the status quo, which is costing them cash every quarter. In the end, common holders not wise enough to sell during the pump are left holding the bag.
Good luck to VSTA holders -- you might get a lucky break.
P/D shops love brain damaged OTC penny stocks with shelf registrations. They orchestrate a rally (look at PLUG) and generate much trading activity, while steadily establishing a short position. They cover the short with below market S-1 at nice profit and get free warrants as added sweetener. Seen this happen with several companies recently.
This process does produce cash for the company, abet at cost of dilution. It's a lot better for Platinum than the status quo, which is costing them cash every quarter. In the end, common holders not wise enough to sell during the pump are left holding the bag.
Good luck to VSTA holders -- you might get a lucky break.
Everything I post is my biased opinion.
Recent VTGN News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:52:17 PM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 05/19/2026 08:51:49 PM
- Vistagen Appoints Angel S. Angelov, MD, MBA, as Chief Medical Officer • Business Wire • 05/19/2026 12:30:00 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 05/15/2026 08:26:37 PM
- Vistagen to Participate in the 2026 RBC Capital Markets Global Healthcare Conference • Business Wire • 05/14/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/12/2026 11:44:41 AM
- Vistagen Announces Preliminary Positive Data in Ongoing Open-Label Extension Portion of PALISADE-3 Phase 3 Study of Fasedienol for the Acute Treatment of Social Anxiety Disorder • Business Wire • 05/12/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2026 08:30:08 PM
- Vistagen Announces Completion of Last Patient Visit in PALISADE-4 Phase 3 Public Speaking Challenge Study of Fasedienol for Acute Treatment of Social Anxiety Disorder • Business Wire • 05/08/2026 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/28/2026 08:13:15 PM
- Vistagen Therapeutics, Inc. (NASDAQ: VTGN) Investor Alert: Schubert Jonckheer Investigating Possible False Claims Regarding Drug Candidate Following 80% Stock Drop • PR Newswire (US) • 04/28/2026 01:00:00 PM
- Vistagen Receives FDA “Study May Proceed” Letter Under its Refisolone IND Application, Enabling Further Phase 2 Clinical Development for the Treatment of Vasomotor Symptoms (Hot Flashes) due to Menopause • Business Wire • 04/22/2026 12:30:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/13/2026 09:27:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:43:16 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:41:53 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:40:22 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:38:30 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 04/10/2026 12:33:03 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/02/2026 08:16:35 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/18/2026 08:45:49 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/16/2026 08:10:38 PM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/16/2026 06:38:00 AM
- Vistagen Therapeutics, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - VTGN • PR Newswire (US) • 03/12/2026 07:29:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2026 11:02:20 AM
- Contact The Gross Law Firm by March 16, 2026 Deadline to Join Class Action Against Vistagen Therapeutics, Inc.(VTGN) • PR Newswire (US) • 03/10/2026 01:00:00 PM
